LifeMD, Inc. (LFMD)

Over the past six months, LifeMD reported robust full-year 2025 financial results, with revenue increasing by 25% and adjusted EBITDA surging 309%, leading to a stock surge. The company issued positive 2026 financial guidance. LifeMD announced offering Novo Nordisk's Wegovy telehealth subscription program. LifeMD appointed a veteran healthcare finance executive as Chief Financial Officer and expanded its leadership team. Mizuho upgraded LifeMD to Outperform from Neutral. LifeMD's shares declined sharply after reporting Q2 2025 results that prompted a substantial cut in full-year guidance due to persistent challenges in its men's health business, particularly Rex MD.

While specific details on the seasonality of demand for LifeMD, Inc.'s products and services are not explicitly detailed, there might be observable seasonal trends in investor behavior or market response, which could indirectly reflect underlying demand patterns.

LifeMD, Inc. is a direct-to-patient telehealth company providing virtual access to medical professionals for consultations, prescriptions, and ongoing treatment across various health indications in the United States. It operates in the Health Services sector, specifically within the Medical/Nursing Services industry, and is categorized under Health Care Technology. The company's business model is centered on a cash-pay subscription service, bypassing traditional insurance complexities, and offering convenient and discreet care. LifeMD's major products and services include ShapiroMD for hair loss, RexMD for men's health, LifeMD PC for virtual primary care, a weight management program including GLP-1 medications, women's health services, and WorkSimpli for workplace SaaS products.

LifeMD's core telehealth services are primarily offered to patients within the United States. The company leverages a U.S.-based network of board-certified medical professionals and is licensed to operate in all 50 states. Its headquarters are in New York, NY, with an operational footprint also in Boca Raton, FL.

LifeMD's brand reputation is positively influenced by its growth and expansion in the telehealth sector. The company has been recognized for its successful patient acquisition strategies, with active subscribers increasing by 16% year-over-year. Its expansion into GLP-1 weight management programs and growing women's health programs signals a scaling business model. The company's focus on providing honest, affordable, timely, and easy healthcare through technology also contributes to its brand image. LifeMD's vertically integrated, AI-enabled platform and nationwide coverage further support its reputation as a leading platform for comprehensive virtual healthcare.

LifeMD, Inc.'s ownership structure is a mix of institutional, retail, and individual investors. As of August 2025, institutional investors collectively held 57.14% of the company's shares. As of April 9, 2026, LifeMD, Inc. has 106 institutional owners and shareholders holding a total of 19,134,878 shares. Major institutional shareholders include BlackRock, Inc., The Vanguard Group, Inc., and Renaissance Technologies Llc. CEO Justin Schreiber owned 2,703,715 shares as of June 2025, representing 5.7% of the company. As of March 2024, the management team and founders collectively held approximately 25% of the company's shares.